Schroder Investment Management Group Taro Pharmaceutical Industries LTD Transaction History

Schroder Investment Management Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$74.18 - $97.92 $6.29 Million - $8.3 Million	-84,800 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$75.36 - $86.57 $1.39 Million - $1.6 Million	18,500 Added 27.9%	84,800 $6.46 Million
Q2 2019 Aug 08, 2019	BUY	$83.92 - $108.88 $1.06 Million - $1.37 Million	12,600 Added 23.46%	66,300 $5.66 Million
Q1 2019 May 14, 2019	BUY	$85.97 - $108.09 $4.62 Million - $5.8 Million	53,700 New	53,700 $5.8 Million
Q3 2018 Nov 13, 2018	SELL	$97.82 - $116.09 $2.39 Million - $2.83 Million	-24,416 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$97.62 - $120.59 $22.8 Million - $28.2 Million	-233,504 Reduced 90.53%	24,416 $2.81 Million
Q1 2018 May 11, 2018	SELL	$95.91 - $107.26 $16.2 Million - $18.1 Million	-168,535 Reduced 39.52%	257,920 $25.5 Million
Q4 2017 Feb 09, 2018	SELL	$104.5 - $126.38 $14.2 Million - $17.2 Million	-135,983 Reduced 24.18%	426,455 $44.7 Million
Q3 2017 Nov 09, 2017	BUY	$97.26 - $116.2 $54.7 Million - $65.4 Million	562,438	562,438 $62.9 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.